Ticker Details
Abbott Laboratories Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.
IPO Date:	December 24, 1981
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$165.9B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.60 | 0.86%
Avg Daily Range (30 D):	$1.07 | 1.01%
Avg Daily Range (90 D):	$1.05 | 0.93%

Institutional Daily Volume
Avg Daily Volume:	5.67M
Avg Daily Volume (30 D):	8.34M
Avg Daily Volume (90 D):	7.61M

Trade Size
Avg Trade Size (Sh.):	143
Avg Trade Size (Sh.) (30 D):	73
Avg Trade Size (Sh.) (90 D):	71

Institutional Trades
Total Institutional Trades:	101,567
Avg Institutional Trade:	$5.74M
Avg Institutional Trade (30 D):	$18.64M
Avg Institutional Trade (90 D):	$15.28M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	17

Market Closing Trades
Avg Closing Trade:	$54.02M
Avg Closing Trade (30 D):	$240.47M
Avg Closing Trade (90 D):	$186.04M
Avg Closing Volume:	653.25K

News

Apr 17, 2026 @ 4:00 PM China Diabetes Devices Market Forecast and Company... Source: Researchandmarkets.Com

Apr 17, 2026 @ 3:17 PM Abbott Stock Crash: Rebound Could Be Coming Fast Source: Thomas Hughes

Apr 17, 2026 @ 12:36 PM Stock Market Today: Wall Street Set To Extend Rall... Source: Eva Mathew

Apr 16, 2026 @ 11:22 PM Why Abbott Laboratories Stock Tumbled on Thursday Source: Eric Volkman

Apr 16, 2026 @ 5:06 PM Wall Street Hits New Records, Oil Surges On Hormuz... Source: Piero Cingari

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$3.73		$3.73
Diluted EPS	$3.72		$3.72
Revenue	$44.33B		$44.33B
Gross Profit	$25.01B		$25.01B
Net Income / Loss	$6.52B		$6.52B
Operating Income / Loss	$8.05B		$8.05B
Cost of Revenue	$19.32B		$19.32B
Net Cash Flow	$835M		$835M
PE Ratio	26.06